SynBioBeta Speaker

Nicholas Larus-Stone

Benchling

Head of AI Agents

Nicholas Larus-Stone is head of the AI Agents team at Benchling, where he leads development of the company’s scientific agents and other AI-driven products. He joined Benchling following its acquisition of Sphinx Bio, the biotech startup he founded to apply AI to scientific data analysis and drug discovery. Earlier in his career, he was the first software engineer at Octant Bio and led the Machine Learning Infrastructure team at BenevolentAI. Nicholas also is the founder and president of Bits in Bio, a leading non-profit uniting innovators in software and life sciences.

Sessions Featuring

Nicholas

This Year

Breakout Session

•

4:30 PM

-

5:15 PM

Tools & Tech

AI Co-Scientists: From Pipettes to Protocols

Biology is entering an era where AI agents don’t just analyze data — they co-design, plan, and execute experiments. Multi-agent systems like CRISPR-GPT demonstrate how AI can act as a true lab co-pilot: decomposing complex genome editing projects into stepwise workflows, selecting tools, troubleshooting, and even drafting protocols that allow junior researchers to perform sophisticated edits on their first attempt . Beyond CRISPR, new systems like BioMARS integrate reasoning agents with robotics, while biotech companies are testing “AI lab assistants” that monitor and adjust experiments in real time. This session explores how multi-agent copilots are making biology more reproducible, democratizing complex workflows, and pushing the boundaries of lab autonomy. The central question: when AI can plan, troubleshoot, and validate experiments end-to-end, how should scientists and institutions govern this new power?

Featuring

Le Cong

Stanford University

Associate Professor

CRISPR-GPT creator: AI co-pilot for gene editing.

Nicholas Larus-Stone

Benchling

Head of AI Agents

Bits in Bio founder building AI agents for science.

George Peabody

Ginkgo Bioworks

Program Lead

Anna Marie Wagner

Transfyr

Co-founder & CEO

Breakout Session

•

4:30 PM

-

5:15 PM

Tools & Tech

AI Co-Scientists: From Pipettes to Protocols

Biology is entering an era where AI agents don’t just analyze data — they co-design, plan, and execute experiments. Multi-agent systems like CRISPR-GPT demonstrate how AI can act as a true lab co-pilot: decomposing complex genome editing projects into stepwise workflows, selecting tools, troubleshooting, and even drafting protocols that allow junior researchers to perform sophisticated edits on their first attempt . Beyond CRISPR, new systems like BioMARS integrate reasoning agents with robotics, while biotech companies are testing “AI lab assistants” that monitor and adjust experiments in real time. This session explores how multi-agent copilots are making biology more reproducible, democratizing complex workflows, and pushing the boundaries of lab autonomy. The central question: when AI can plan, troubleshoot, and validate experiments end-to-end, how should scientists and institutions govern this new power?

Featuring

Le Cong

Stanford University

Associate Professor

CRISPR-GPT creator: AI co-pilot for gene editing.

Nicholas Larus-Stone

Benchling

Head of AI Agents

Bits in Bio founder building AI agents for science.

George Peabody

Ginkgo Bioworks

Program Lead

Anna Marie Wagner

Transfyr

Co-founder & CEO

Previous Speakers Include